Editorial
-
Human Papillomavirus Vaccination: Overcoming Barriers to Hesitancy in the GCC Countries
Salah Al Awaidy, Thuria Al Rawahi, Faryal Khamis, Jaffar A. Al-Tawfiq
Case Reports
-
An Extremely High Preoperative CA19-9 Cannot Exclude the Diagnosis of Xanthogranulomatous Cholecystitis: A Case Report and Literature Review
Mahmood Masud Al Awfi, Salah Al Jabri, Yahya Al Azri, Zakiya Al Ajmi
Xanthogranulomatous cholecystitis is a rare idiopathic benign chronic inflammatory condition with a locally aggressive spread. Its clinical and radiological manifestation are variable and unpredictable. While it shares similarities with gallbladder cancer, Xanthogranulomatous cholecystitis does not necessitate aggressive surgical treatment. However, the considerable challenge to reach a preoperative diagnosis underscores the need for an aggressive surgical approach. Adding to this challenge, an extremely elevated CA19-9 is no longer a distinguishing factor.
Keywords:Xanthogranulomatous cholecystitis; CA19-9 Antigen.
-
Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report
Amro Nagy, Muhammad Yaqut, Doaa Abbas, Amna Mohamed
Over 160 cases of subacute thyroiditis (SAT) following COVID-19 vaccination or infection have been reported in the literature. Roughly one-half were attributed to either the first or second dose of the COVID-19 vaccine. We report a rare case of SAT in a 47-year-old male patient with a history of clear cell renal cell carcinoma and advanced chronic kidney disease, among other comorbidities, excluding thyroid disease. After he received the third dose of the Pfizer mRNA vaccine, a deranged thyroid profile was accidentally discovered. His SAT remained asymptomatic and normalized in about six months without treatment. SAT post-COVID vaccination is a self-limiting and rare condition that should be considered in the differential diagnosis of silent thyroiditis.
Keywords:Subacute Thyroiditis; mRNA Vaccines; COVID-19; Pfizer-BioNTech COVID-19 Vaccine; ASIA Syndrome; Oman.
Letter to the Editor
-
Decoding Sleep and Cardiovascular Risk: Methodological Insights and Bridging Culture Factors